---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-048687"
form_type: "8-K"
ticker: "DMII"
cik: "0002040475"
company_name: "Drugs Made In America Acquisition II Corp."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T03:18:42.865138+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Drugs Made In America Acquisition II Corp. updates CFO and CEO compensation, grants equity upon business combination

## Summary
- CFO Saleem Elmasri's monthly fee remains $3,500; equity grant increases from 100,000 to 175,000 shares earned at execution of definitive agreement.
- CEO Roger Bendelac receives $4,500/month ($2,500 current, $2,000 deferred) and 250,000 shares earned upon signing a definitive business combination agreement.
- Both equity grants are to be issued at closing of the initial business combination, within ten days thereafter.
- Updated Statement of Work with Titan Advisory Services LLC and CEO Compensation Agreement with Aleutian Equity Holdings LLC were entered on April 22, 2026.

## SEC filing metadata
- accession: 0001213900-26-048687
- form_type: 8-K
- ticker: DMII
- cik: 0002040475
- company_name: Drugs Made In America Acquisition II Corp.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/0001213900-26-048687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea0287975-8k_drugs2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-048687
- JSON: https://secwatch.observer/filing/0001213900-26-048687.json
- Plain text: https://secwatch.observer/filing/0001213900-26-048687.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.